Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
August 10, 2023 at 11:56 AM EDT
Inversago's drugs use a different approach than most treatments in the obesity and diabetes space.
Photography by Christophe Tomatis